The Sisonke study team is launching the Sherpa Study that will assess the Moderna booster in protecting against COVID-19 infections and severe COVID-19 disease among healthcare workers.
CAPE TOWN - South African medical scientists will now evaluate the efficacy of Moderna’s coronavirus vaccine as a booster shot.
The study, sponsored by the South African Medical Research Council and co-funded by Moderna, sets out to enroll up to 15,000 participants who have received either a single or two doses of the Johnson & Johnson COVID-19 vaccine as part of the Sisonke study for healthcare workers. Sherpa co-principal investigator, Doctor Nigel Garret, explains: "It's now about six months after the second dose for many healthcare workers. Some of them have perhaps taken up [the] Pfizer [booster] and as the Department of Health, we have now been able to get sufficient vaccine to the research side to also offer the Moderna booster to the South African healthcare workers that participated in Sisonke.
Scientists said that the study would allow researchers to investigate the efficacy of the Moderna COVID-19 vaccine booster against the new variants in South Africa and would provide the South African Health Products Regulatory Authority with additional data on this vaccine for potential licensing.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
COVID-19: North Korea lifts Covid-19 lockdown amid ‘stable’ virus situationSEOUL, May 30 (Reuters) - North Korea has lifted movement restrictions imposed in the capital Pyongyang after its first admission of Covid-19 outbreak weeks ago, media reported, as the isolated country says the virus situation is now under control.
Read more »
Covid-19 update: 1,004 new cases and 16 deaths reported in SA | The CitizenGauteng continued to report the highest number of cases, with 43% of cases coming from the province.
Read more »
Ivermectin terminated as a treatment for Covid-19 in SA | The CitizenSahpra said there is no credible evidence that Ivermectin helps treat Covid-19
Read more »
Ivermectin for Covid-19 discontinued in SA amid lack of credible data, declining interestGiven that there is currently no credible evidence to support a therapeutic role for ivermectin in Covid-19, the SA Health Products Regulatory Authority has decided to terminate its controlled access programme with immediate effect.
Read more »
Ivermectin for Covid-19 discontinued in SA amid lack of credible data, declining interestGiven that there is currently no credible evidence to support a therapeutic role for ivermectin in Covid-19, the SA Health Products Regulatory Authority has decided to terminate its controlled access programme with immediate effect.
Read more »
Covid-19 update: 2,809 new cases and 5 deaths reported in SA | The CitizenThere has been an increase of 103 hospital admissions in the past 24 hours.
Read more »